
CareFusion taps Boston Scientific exec Bose for board | Personnel Moves
May 9, 2014 by Brad Perriello

CareFusion said it named Supratim Bose, an executive at Boston Scientific (NYSE:BSX) who spent 30 years at Johnson & Johnson, to its board of directors.
Bose has been president of Asia-Pacific, Middle East and Africa for Boston Scientific since January 2013. The 30-year veteran of Johnson & Johnson was chairman of J&J’s medical devices & diagnostics business throughout Asia-Pacific, where he pioneered its entry in all emerging markets in Asia, including China, India, and Vietnam. Read more
Ex-clinical affairs veep Napoli sues Wright Medical
May 7, 2014 by Brad Perriello

The former vice president for clinical & regulatory affairs at Wright Medical, who left under a cloud in 2011, is suing her former employer in a bid to win severance pay.
Alicia Napoli was part of a purge of Wright executives in April and May of that year that saw then-CEO Gary Henley abruptly resign and then-CTO Frank Bono fired. Napoli, senior vice president, general counsel and secretary Raymond Kolls and senior vice president for EMEA commercial operations Cary Hagan left a month later. Read more
Medtech makers continue shift in CEO pay
May 8, 2014 by Brad Perriello
Medical device companies are shifting the way they pay their CEOs, moving away from equity-based awards toward compensation pegged to financial metrics that are more aligned with shareholders’ interests, according to a report from Morgan Stanley.
Yet many companies – 40% of Morgan Stanley’s coverage universe – still use earnings per share as a part of their short-term incentive programs, even though short-term EPS metrics aren’t correlated to total shareholder return, according to the report. Only 15% of the companies the investment house reviewed – Baxter, Becton, Dickinson & Co. and Medtronic – used return on invested capital as a metric “and most underweight the metric,” the Morgan Stanley analysts wrote. Read more
Medtronic taps GE Healthcare exec to lead diabetes unit
May 13, 2014 by Brad Perriello

Medtronic said today that it named a former GE Healthcare executive, Hooman Hakami, as president of its global diabetes group.
Hakami was president & CEO of GE Healthcare’s $2 billion detection & guidance systems business and led its interventional systems business from 2009 to 2012, according to a press release. Medtronic’s diabetes business put up $1.53 billion in revenues during its last fiscal year ending April 26, 2013. Read more